Weight Loss and ExeRcise

NCT ID: NCT06322030

Last Updated: 2025-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2028-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Weight loss interventions for neurologically health individuals have established benefits for improving physical and psychosocial function. The investigators believe that Veterans who have had a stroke would realize similar benefits and that the effects would be enhanced with concurrent exercise training. The investigators will study the effects of a 15-week lifestyle management program to determine if it can effectively improve some of the physical and psychosocial problems common in Veterans who have had a stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More than 2 million stroke survivors currently living in the U.S. are obese. Obesity is known to exacerbate age-related declines in function in these individuals and is associated with poorer clinical outcomes and quality of life. Weight-loss interventions are well-studied in neurologically healthy individuals and are shown to be effective for attenuating functional decline and improving quality of life. Despite these established benefits, there is currently an absence of studies investigating the effects of intentional weight loss on physical and/or psychosocial function in individuals following stroke. The investigators propose a trial aimed at Enhancing Mobility and Psychosocial function in Obese Veterans following stroke via Weight loss and ExeRcise (EMPOWER). This trial leverages a 15-week multidisciplinary approach to weight loss, via an existing lifestyle and weight management program, including caloric restriction, with or without concurrent supervised exercise training, as the catalyst by which remediation of physical and psychosocial impairments promote enhanced recovery in obese Veteran survivors of stroke. The investigators posit that successful weight loss will result in improvements in physical and psychosocial function (compared to control subjects) and that concurrent exercise will result in improved outcomes when compared to weight loss alone. The VHA 2010 Management of Stroke Rehabilitation Guidelines recommends that patients receive a formal rehabilitation assessment, the results of which should be used to determine the appropriate level of care and develop evidence-based interventions. However, without information regarding the effects of obesity and weight management on physical and psychosocial function as well as data on the long-term benefits of the program, evidence to guide decisions regarding the most appropriate approach to post-stroke rehabilitation for obese Veteran stroke survivors will remain elusive and recommendations for best available treatment cannot be met. Data from the proposed trial will have important clinical significance by determining the extent to which this type of program improves (or not) physical and psychosocial outcomes in Veterans following stroke and will provide a foundation for future studies aimed at establishing effectiveness of this approach to post-stroke care for Veterans.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The investigators will utilize a 2x2 factorial design to assess for changes in our outcomes over time between treatment groups.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The coordinator will not see group assignment, only a patient number which is entered into a software package.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diet

15 week weight management program

Group Type EXPERIMENTAL

FOCUS-15 Lifestyle Management Program

Intervention Type DIETARY_SUPPLEMENT

15 week weight management program

Control

waitlist control

Group Type NO_INTERVENTION

No interventions assigned to this group

Exercise

exercise training

Group Type EXPERIMENTAL

Exercise Training

Intervention Type BEHAVIORAL

15 weeks of progressive exercise training

Diet + Exercise

15 week weight management program + exercise training

Group Type EXPERIMENTAL

FOCUS-15 Lifestyle Management Program

Intervention Type DIETARY_SUPPLEMENT

15 week weight management program

Exercise Training

Intervention Type BEHAVIORAL

15 weeks of progressive exercise training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FOCUS-15 Lifestyle Management Program

15 week weight management program

Intervention Type DIETARY_SUPPLEMENT

Exercise Training

15 weeks of progressive exercise training

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Diet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of stroke at least 6 months prior
* BMI \> 30 kg/m2
* Residual paresis in the lower extremity (Fugl-Meyer LE motor score \<34)
* Ability to follow instructions, complete training and testing and to communicate exertion, pain and distress
* Provision of informed consent

Exclusion Criteria

* Unable to ambulate at least 150 feet or experienced intermittent claudication while walking
* Unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during ADL's
* Dementia
* Life expectancy \<1 yr
* History of DVT or pulmonary embolism within 6 months
* Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
* Severe hypertension with systolic \>200 mmHg and diastolic \>110 mmHg at rest
* Current enrollment in a rehabilitation trial to enhance motor or psychosocial recovery
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chris M Gregory, PhD

Role: PRINCIPAL_INVESTIGATOR

Ralph H. Johnson VA Medical Center, Charleston, SC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ralph H. Johnson VA Medical Center, Charleston, SC

Charleston, South Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah A Jackson, BA MA

Role: CONTACT

(843) 789-6700

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

R. Amanda C LaRue, PhD

Role: primary

843-789-6707

Thad Abrams, MD

Role: backup

(319) 338-0581 ext. 7618

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RX004281

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

PRO0120848

Identifier Type: OTHER

Identifier Source: secondary_id

N4281-R

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise Primed Stroke Rehabilitation
NCT04877444 RECRUITING EARLY_PHASE1